Free Trial

The Allstate Co. (NYSE:ALL) Shares Sold by Artemis Investment Management LLP

Allstate logo with Finance background

Artemis Investment Management LLP reduced its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 50.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 301,231 shares of the insurance provider's stock after selling 304,461 shares during the quarter. Artemis Investment Management LLP owned about 0.11% of Allstate worth $57,128,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of ALL. Rise Advisors LLC purchased a new position in Allstate in the first quarter worth about $26,000. Northwest Investment Counselors LLC bought a new stake in shares of Allstate in the 1st quarter valued at approximately $26,000. Versant Capital Management Inc boosted its holdings in shares of Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider's stock worth $30,000 after purchasing an additional 78 shares during the period. Family Firm Inc. bought a new position in shares of Allstate during the 2nd quarter valued at approximately $38,000. Finally, MCF Advisors LLC raised its holdings in Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider's stock valued at $53,000 after buying an additional 84 shares during the period. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate Stock Up 1.1 %

Shares of NYSE:ALL traded up $1.95 during trading hours on Wednesday, hitting $184.82. The company's stock had a trading volume of 1,003,226 shares, compared to its average volume of 1,549,823. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36. The firm's fifty day moving average price is $183.60 and its 200 day moving average price is $172.72. The Allstate Co. has a 52 week low of $113.04 and a 52 week high of $193.97. The company has a market capitalization of $48.78 billion, a price-to-earnings ratio of 40.77, a P/E/G ratio of 1.81 and a beta of 0.48.

Allstate (NYSE:ALL - Get Free Report) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $1.28. The company had revenue of $15.71 billion during the quarter, compared to analyst estimates of $14.04 billion. Allstate had a return on equity of 24.05% and a net margin of 5.03%. Allstate's revenue was up 12.4% on a year-over-year basis. During the same quarter in the prior year, the business earned ($4.42) earnings per share. As a group, research analysts expect that The Allstate Co. will post 15.2 EPS for the current year.

Allstate Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Friday, August 30th were given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 1.99%. The ex-dividend date of this dividend was Friday, August 30th. Allstate's payout ratio is 81.24%.

Insider Buying and Selling at Allstate

In related news, CEO Thomas J. Wilson sold 90,000 shares of the business's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares in the company, valued at $15,880,915.68. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, CEO Thomas J. Wilson sold 90,000 shares of the firm's stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the sale, the chief executive officer now owns 88,552 shares of the company's stock, valued at $15,880,915.68. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Suren Gupta sold 45,775 shares of the business's stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $177.28, for a total value of $8,114,992.00. Following the sale, the insider now owns 89,930 shares in the company, valued at $15,942,790.40. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 238,305 shares of company stock valued at $43,082,657. 1.80% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms have commented on ALL. Evercore ISI lifted their price objective on shares of Allstate from $191.00 to $195.00 and gave the stock an "in-line" rating in a research note on Wednesday. Wells Fargo & Company dropped their price target on shares of Allstate from $177.00 to $175.00 and set an "equal weight" rating for the company in a research note on Friday, August 16th. Bank of America increased their price objective on shares of Allstate from $213.00 to $226.00 and gave the stock a "buy" rating in a research report on Thursday, August 1st. Roth Mkm reissued a "buy" rating and issued a $200.00 price objective on shares of Allstate in a research note on Wednesday, August 14th. Finally, JPMorgan Chase & Co. upped their target price on Allstate from $193.00 to $200.00 and gave the company an "overweight" rating in a research note on Thursday, July 11th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $199.41.

View Our Latest Analysis on ALL

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Further Reading

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

→ Banking failure dead ahead (From Porter & Company) (Ad)

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside
Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines